SOURCE: SkyePharma PLC

May 01, 2007 10:14 ET

SkyePharma PLC - Re: UBS Conference

London, UK -- (MARKET WIRE) -- May 1, 2007 --

                SKYEPHARMA TO PRESENT AT 2007 UBS GLOBAL
           GENERIC & SPECIALTY PHARMACEUTICALS CONFERENCE

LONDON, UK, MAY 1, 2007-- SkyePharma PLC (LSE: SKP; NASDAQ: SKYE) today announces that the Company's Chief Executive Officer, Frank Condella, will make a presentation at 2007 UBS Global Generic & Specialty Pharmaceuticals Conference in New York, USA. Mr Condella will deliver his presentation on Tuesday 8 May 2007 at 4.30 p.m. (GMT). Investors may access a live webcast of the presentation at www.skyepharma.com under the Investor Relations tab. The presentation will be archived for 3 months.

For further information please contact:


SkyePharma PLC
+44 207 491 1777
Frank Condella, Chief Executive Officer
Ken Cunningham, Chief Operating Officer
Peter Grant, Finance Director


Financial Dynamics
+44 207 7831 3113
David Yates
Deborah Scott


The Trout Group
+ 1 617 583 1308
Seth Lewis

About SkyePharma PLC

Using its proprietary drug delivery technologies, SkyePharma develops new formulations of known molecules to provide a clinical advantage and life-cycle extension. The Company has ten approved products in the areas of oral, inhalation and topical delivery that are marketed throughout the world by leading pharmaceutical companies. For more information, visit www.skyepharma.com.



                  This information is provided by RNS
       The company news service from the London Stock Exchange